MRCH.F Stock Overview
Operates healthcare business in Japan, the United States, Europe, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 3/6 |
H.U. Group Holdings, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥15.97 |
52 Week High | JP¥19.07 |
52 Week Low | JP¥14.45 |
Beta | 0.47 |
11 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | -39.05% |
5 Year Change | n/a |
Change since IPO | -22.66% |
Recent News & Updates
Recent updates
Shareholder Returns
MRCH.F | US Healthcare | US Market | |
---|---|---|---|
7D | 0% | 3.3% | 2.2% |
1Y | n/a | 4.9% | 32.6% |
Return vs Industry: Insufficient data to determine how MRCH.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how MRCH.F performed against the US Market.
Price Volatility
MRCH.F volatility | |
---|---|
MRCH.F Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 6.6% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.8% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MRCH.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MRCH.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1950 | 5,295 | Shigekazu Takeuchi | www.hugp.com |
H.U. Group Holdings, Inc., together with its subsidiaries, operates healthcare business in Japan, the United States, Europe, and internationally. The Lab Testing and Its Related Services segment collects specimens from medical offices, clinics, and hospitals, and conducts various tests at its laboratories. The segment also provides precision of the tests, pre-trial setup work, specimen collection and transport, measuring, result reports, and data management services for support in research and development of medicine.
H.U. Group Holdings, Inc. Fundamentals Summary
MRCH.F fundamental statistics | |
---|---|
Market cap | US$1.04b |
Earnings (TTM) | -US$51.86m |
Revenue (TTM) | US$1.63b |
0.6x
P/S Ratio-20.0x
P/E RatioIs MRCH.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MRCH.F income statement (TTM) | |
---|---|
Revenue | JP¥236.95b |
Cost of Revenue | JP¥173.72b |
Gross Profit | JP¥63.24b |
Other Expenses | JP¥70.79b |
Earnings | -JP¥7.55b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Nov 08, 2024
Earnings per share (EPS) | -132.93 |
Gross Margin | 26.69% |
Net Profit Margin | -3.19% |
Debt/Equity Ratio | 49.2% |
How did MRCH.F perform over the long term?
See historical performance and comparison